Oxford's portfolio is comprised of life science companies engaged in research and development and manufacturing of human therapeutics, diagnostics and medical devices. These companies are at all stages of growth, from Series A through post-IPO. Although our clients are worldwide, they are primarily U.S. firms based in the Mid-Atlantic and on the East and West Coasts. The vast majority of our portfolio companies is backed by institutional equity and venture capital investors.